Manufacturer Meloxicam Powder Synthetic EP Grade For Rheumatoid arthritis
Meloxicam Specification
Product Name: Meloxicam
CAS: 71125-38-7
Standard: EP
Natural/Synthetic: Synthetic
Level: Pharmaceutical grade
Content: 99%
Appearance: light yellow powder
Packing: 25kg/cardboard drum
Ingredients: Meloxicam
Category: Pharmaceutical Raw Materials
Industry: Pharmaceuticals
Field: Pharmaceutical Raw Materials
Deferred products: meloxicam tablets, meloxicam dispersible tablets, preparations
Application: Symptomatic treatment for rheumatoid arthritis, symptomatic treatment of painful osteoarthritis (arthropathy, degenerative osteoarthrosis)
Usage and dosage: Oral. The daily dose should not exceed 15 mg/day. Patients with severe renal failure requiring dialysis should not exceed 7.5 mg/day. 1. When symptoms of osteoarthritis worsen: 1 tablet at a time, once daily, if the symptoms do not improve, the dose may be increased to 2 tablets once a day, once a day; each tablet is 7.5 mg. 2. Rheumatoid arthritis and ankylosing spondylitis: 2 tablets at a time, once daily, according to the response after treatment, the dose can be reduced to one tablet at a time, once a day; 7.5 mg per tablet.
What is Meloxicam?
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and fever reducer effects. It is an oxicam closely related to piroxicam, and falls in the enolic acid group of NSAIDs.
Meloxicam Certificate of Analysis
Product name |
Meloxicam |
CAS No. |
71125-38-7 |
Outer Packing |
20kg/drum |
Production date |
2017-12-29 |
Shelf life |
2020-12-28 |
Standard adopted |
EP8.0 |
Items of analysis |
Specification |
Results |
Appearance |
A pale yellow powder |
A pale yellow powder |
Identification |
Should comply with the IR spectrum
|
Comply with the IR spectrum |
Related substances |
|
|
Impurity A |
≤0.1% |
<0.03% |
Impurity B |
≤0.1% |
Not detected |
Impurity C |
≤0.05% |
Not detected |
Impurity D |
≤0.05% |
<0.03% |
Any other impurity |
≤0.10% |
<0.03%﹙350nm﹚ |
Total impurities |
≤0.3% |
0.07% |
Heavy Metals |
≤20ppm |
<20 ppm |
Loss on drying |
≤0.5% |
0.03% |
Sulphated ash |
≤0.1% |
0.02% |
Assay,on dried basis |
99.0%~101.0% |
99.5% |
Residual solvents |
|
|
Ethanol |
≤5000ppm |
263ppm |
Xylene |
≤2170 ppm |
Not detected |
Conclusion |
Qualified |
Meloxicam Application
Meloxicam is used to treat arthritis. It reduces pain, swelling, and stiffness of the joints.